Deal title

Principal company

Partner
company

Total projected at signing (US$M)

Technologies

Date

April

Hitachi Chemical acquires Apceth Biopharma

Apceth Biopharma GmbH

Hitachi Chemical Co. Ltd.

$85.20

Service laboratory deal; cell therapy

4/4/19

Ethicon acquires Auris Health

Auris Health Inc.

Ethicon Inc.

$5,750.00

Other technologies

4/1/19

Novartis acquires Cellforcure

Cellforcure

Novartis AG

Payment unspecified

Manufacturing facility deal; service laboratory deal; gene therapy; cell therapy

4/1/19

Ipsen acquires Clementia Pharmaceuticals

Clementia Pharmaceuticals Inc.

Ipsen SA

$1,303.00

Small molecule therapeutic; ophthalmic formulation; ophthalmic liquid formulation; oral formulation

4/18/19

Zentiva acquires Creo Pharmaceuticals

Creo Pharmaceuticals Ltd.

Zentiva a.s. Praha

Payment unspecified

Generic product; service laboratory deal; small molecule therapeutic

4/1/19

Nichi-Iko acquires Elmed

Elmed

Nichi-Iko Pharmaceutical Co. Ltd.

Payment unspecified

Generic product

4/1/19

Evolution Research Group acquires Finger Lakes Clinical Research

Finger Lakes Clinical Research

Evolution Research Group LLC

Payment unspecified

Service laboratory deal

4/1/19

Precision acquires Helomics

Helomics Corp.

Precision Therapeutics Inc.

Payment unspecified

Other technologies; service laboratory deal

4/5/19

Merck Sharp and Dohme acquires Immune Design

Immune Design Corp.

Merck Sharp and Dohme Corp.

$300.00

Small molecule therapeutic; vaccine; gene therapy; immuno-oncology; protein recombinant

4/2/19

Vital Therapies acquires Immunic

Immunic AG

Vital Therapies

Payment unspecified

Small molecule therapeutic; oral formulation; tablet formulation

4/12/19

Sarepta Therapeutics acquires Myonexus Therapeutics

Myonexus Therapeutics Inc.

Sarepta Therapeutics Inc.

$165.00

Gene transfer system viral; gene therapy; biological therapeutic; infusion; intra-arterial formulation; intramuscular formulation; intravenous formulation; virus recombinant

4/4/19

Pacira Pharmaceuticals acquires Myoscience

Myoscience Inc.

Pacira Biosciences Inc.

$220.00

Medical device deal

4/9/19

Mereo merges with Oncomed Pharmaceuticals

Oncomed Pharmaceuticals Inc.

Mereo Biopharma Group Ltd.

$95.40

Monoclonal antibody; biological therapeutic; capsule formulation; immuno-oncology; immunoglobulin-G; infusion; intravenous formulation; monoclonal antibody human; monoclonal antibody humanized; multivalent monoclonal antibody; oral formulation; protein recombinant; small molecule therapeutic; tablet formulation

4/23/19

Mateon Therapeutics merges with Oncotelic

Oncotelic Inc.

Mateon Therapeutics Inc.

Payment unspecified

Protein recombinant; biological therapeutic; infusion; intravenous formulation; natural product; prodrug; small molecule therapeutic; systemic formulation unspecified

4/22/19

Gyroscope Therapeutics merges with Orbit Biomedical to form Gyroscope

Orbit Biomedical Ltd.

Gyroscope Therapeutics Ltd.

$37.63

Gene therapy; gene transfer system; medical device

4/11/19

Smith & Nephew acquires Osiris Therapeutics

Osiris Therapeutics Inc.

Smith & Nephew plc

$660.50

Stem cell therapy; orthopedics deal

4/17/19

Suven Life Sciences' Shore Suven Pharma acquires Rising Pharmaceuticals and Rising subsidiaries

Rising Pharmaceuticals Inc.

Shore Suven Pharma Inc.

Payment unspecified

Generic product

4/22/19

Caprion Biosciences acquires Serametrix

Serametrix Corp.

Caprion Biosciences Inc.

Payment unspecified

Immunoassay; service laboratory deal

4/30/19

Nipro acquires Tanabe Seiyaku Yoshiki Factory

Tanabe Seiyaku Yoshiki Factory Co. Ltd.

Nipro Pharma Corp.

Payment unspecified

Other technologies; animal health deal; service laboratory deal

4/1/19

Therillia acquires Tavec Pharmaceuticals

Tavec Pharmaceuticals Inc.

Therillia Development Company Inc.

Payment unspecified

Gene therapy; gene transfer system

4/18/19

Stagebio merges with Tox Path Specialists

Tox Path Specialists LLC

Stagebio

Payment unspecified

Other technologies; service laboratory deal

4/11/19

Canopy Biosciences acquires Zellkraftwerk

Zellkraftwerk GmbH

Canopy Biosciences LLC

Payment unspecified

Other device deal

4/29/19

May

H. Lundbeck acquires Abide Therapeutics

Abide Therapeutics Inc.

H. Lundbeck A/S

$400.00

Small molecule therapeutic; capsule formulation; oral formulation

5/29/19

Alliqua Biomedical merges with Adynxx

Alliqua Biomedical Inc.

Adynxx Inc.

Payment unspecified

Manufacturing facility deal; cosmetics deal; medical device deal

5/6/19

Ever Pharma Holding acquires Amneal Deutschland

Amneal Deutschland GmbH

Ever Neuro Pharma

Payment unspecified

Generic product

5/17/19

Bison Capital reverse merges with Xynomic Pharmaceuticals

Bison Capital Acquisition Corp.

Xynomic Pharmaceuticals Inc.

$450.00

Small molecule therapeutic; crystalline form

5/14/19

Thermo Fisher Scientific acquires Brammer Bio

Brammer Biopharmaceuticals LLC

Thermo Fisher Scientific Inc.

$1,700.00

Gene transfer system viral; service laboratory deal

5/1/19

Canopy Growth acquires C3 Cannabinoid Compound Company

C3 - Cannabinoid Compound Company GmbH

Canopy Growth Corp.

$256.50

Natural product

5/2/19

Ampliphi Biosciences merges with C3J Therapeutics

C3J Therapeutics Inc.

Ampliphi Biosciences Corp.

Payment unspecified

Bacteriophage recombinant; natural product

5/9/19

Cure Pharmaceutical acquires Chemistry Holdings

Chemistry Holdings Inc.

Cure Pharmaceutical Inc.

$10.00

Drug delivery device deal; formulation

5/14/19

Novartis acquires IFM Tre

IFM Tre

Novartis AG

$1,575.00

Small molecule therapeutic; systemic formulation

5/8/19

Tetra Bio-Pharma acquires Panag Pharma

Panag Pharma Inc.

Tetra Bio-Pharma Inc.

$27.00

Dermatological formulation; natural product

5/1/19

Catalent acquires Paragon Bioservices

Paragon Bioservices Inc.

Catalent Inc

$1,200.00

Gene transfer system; gene therapy; service laboratory deal

5/20/19

Highbridge Capital Management acquires Pernix Therapeutics

Pernix Therapeutics Holdings Inc.

Highbridge Capital Management LLC

$75.60

Generic product; OTC product; small molecule therapeutic

5/1/19

Zentiva acquires Solacium

Solacium Pharma

Zentiva a.s. Praha

Payment unspecified

Generic product; OTC product

5/31/19

June

Bio-Techne acquires B-mogen Biotechnologies

B-mogen Biotechnologies Inc.

Bio-Techne Corp.

Payment unspecified

Genomics; service laboratory deal

6/4/19

Kiadis acquires Cytosen Therapeutics

Cytosen Therapeutics Inc.

Kiadis Pharma Netherlands BV

$109.50

Cell therapy; lymphocyte; T-lymphocyte

6/6/19

Oncternal Therapeutics acquires Gtx in a reverse merger transaction

Gtx Inc.

Oncternal Therapeutics Inc.

Payment unspecified

Small molecule therapeutic

6/7/19

Eurofarma acquires Medipharm

Laboratorio Medipharm Ltda

Eurofarma

Payment unspecified

Small molecule therapeutic; service laboratory deal

6/19/19

Tungsten Bidco acquires Nightstar Therapeutics

Nightstar Therapeutics plc

Tungsten Bidco Ltd. (a wholly owned indirect subsidiary of Biogen Inc.)

$800.00

Gene transfer system viral; biological therapeutic; infusion; injectable formulation; intravenous formulation; ophthalmic formulation; parenteral formulation unspecified; virus recombinant

6/7/19

NLPBI acquires Pairimmune

Pairimmune Inc.

Neomed-Labs

Payment unspecified

Other technologies; service laboratory deal; vaccine

6/6/19

FSD Pharma acquires Prismic Pharmaceuticals

Prismic Pharmaceuticals Inc.

FSD Pharma Inc.

$17.50

Small molecule therapeutic

6/28/19

Cutispharma acquires Silvergate Pharmaceuticals

Silvergate Pharmaceuticals Inc.

Cutispharma Inc.

Payment unspecified

Small molecule therapeutic

6/12/19

Invitae acquires Singular Bio

Singular Bio Inc.

Invitae

$55.00

Genetic screening; genomics

6/19/19

Stellar Biotechnologies reverse merges with Edesa Biotech

Stellar Biotechnologies Inc.

Edesa Biotech

Payment unspecified

Small molecule therapeutic

6/7/19

Merck acquires Tilos Therapeutics

Tilos Therapeutics

Merck & Co. Inc.

$773.00

Antibody

6/30/19

Novoheart Holdings acquires Xellera Therapeutics

Xellera Therapeutics Ltd.

Novoheart Holdings Ltd.

$25.42

Cell therapy; gene transfer system

6/29/19

July

Ligand acquires Ab Initio Biotherapeutics

Ab Initio Biotherapeutics Inc.

Ligand Pharmaceuticals Inc.

$12.00

Small molecule therapeutic; antigen

7/23/19

Boehringer Ingelheim acquires Amal Therapeutics

Amal Therapeutics SA

Boehringer Ingelheim International GmbH

$477.53

Peptide; biological therapeutic; parenteral formulation unspecified; protein recombinant

7/15/19

Pfizer acquires Array Biopharma

Array Biopharma Inc.

Pfizer Inc.

$11,400.00

Small molecule therapeutic; capsule formulation; oral formulation; tablet formulation

7/30/19

Zambon acquires Breath Therapeutics

Breath Therapeutics Holding BV

Zambon Co SpA

$557.00

Peptide; aerosol formulation inhalant; biological therapeutic; inhalant formulation; liposome formulation

7/25/19

Taisho acquires Bristol-Myers's UPSA business with an option

Bristol-Myers Squibb Co.'s UPSA

Taisho Pharmaceutical Co. Ltd.

$1,600.00

OTC product; nutritional supplements and vitamin deal

7/1/19

Harvest One acquires Delivra

Delivra Corp.

Harvest One Cannabis Inc.

$19.50

Small molecule therapeutic; natural product; transdermal formulation

7/3/19

Mynd Analytics acquires Emmaus Life Sciences

Emmaus Life Sciences Inc.

Mynd Analytics Inc.

Payment unspecified

Small molecule therapeutic

7/9/19

Lifespan Biosciences acquires Everest Biotech

Everest Biotech Ltd.

Lifespan Biosciences Inc.

Payment unspecified

Multivalent antibody

7/16/19

Xenetic Biosciences acquires all outstanding shares of Hesperix

Hesperix SA

Xenetic Biosciences Inc.

Payment unspecified

Chimeric antigen receptor T cell therapy

7/22/19

Evotec acquires Just Biotherapeutics

Just Biotherapeutics Inc.

Evotec SE

$90.00

Small molecule therapeutic; biological therapeutic; antibody; biosimilar

7/3/19

Abbvie acquires Mavupharma

Mavupharma Inc.

Abbvie Inc.

Payment unspecified

Small molecule therapeutic; immuno-oncology; oral formulation

7/15/19

Amgen acquires Nuevolution

Nuevolution A/S

Amgen Inc.

$167.00

Small molecule therapeutic

7/30/19

Neubase Therapeutics reverse merges with Ohr Pharmaceutical

Ohr Pharmaceutical Inc.

Neubase Therapeutics Inc.

Payment unspecified

Small molecule therapeutic

7/12/19

Merck acquires Peloton Therapeutics

Peloton Therapeutics Inc.

Merck & Co. Inc.

$2,200.00

Small molecule therapeutic; oral formulation; tablet formulation

7/31/19

Essa acquires Realm Therapeutics

Realm Therapeutics plc

Essa Pharma Inc.

$20.50

Small molecule therapeutic

7/31/19

Salarius merges with Flex Pharma

Salarius Pharmaceuticals LLC

Flex Pharma Inc.

Payment unspecified

Small molecule therapeutic; systemic formulation unspecified

7/19/19

Altimmune acquires Spitfire Pharma

Spitfire Pharma Inc.

Altimmune Inc.

$93.00

Peptide; biological therapeutic; subcutaneous formulation

7/12/19

Pfizer acquires Therachon

Therachon SAS

Pfizer Inc.

$810.00

Peptide; biological therapeutic; recombinant receptor; soluble receptor; subcutaneous formulation

7/1/19

August

Boston Scientific acquires BTG

BTG plc

Boston Scientific Corp.

$4,298.58

Small molecule therapeutic

8/19/19

Jazz Pharmaceuticals acquires Cavion

Cavion LLC

Jazz Pharmaceuticals plc

$312.50

Small molecule therapeutic; oral formulation

8/12/19

Neoleukin merges into Aquinox Pharmaceuticals

Neoleukin Therapeutics Inc.

Aquinox Pharmaceuticals Inc.

Payment unspecified

Biological therapeutic; protein recombinant; systemic formulation unspecified

8/9/19

Genecentric Therapeutics acquires Select Immunogenomics

Select Immunogenomics LLC

Genecentric Therapeutics

Payment unspecified

Biomarker; service laboratory deal; genomics

8/15/19

Asklepios Biopharmaceutical acquires Synpromics

Synpromics Ltd.

Asklepios Biopharmaceutical Inc.

Payment unspecified

Gene transfer system; bioinformatics deal; genomics

8/13/19

The Supreme Cannabis acquires Truverra

Truverra Inc.

The Supreme Cannabis Company

$20.00

Small molecule therapeutic

8/13/19


Notes

Source: Cortellis Deals Intelligence

 

No Comments